Literature DB >> 7525323

PGE2 induces c-fos expression by a cAMP-independent mechanism in glomerular mesangial cells.

M S Simonson1, W H Herman, M J Dunn.   

Abstract

Prostanoids induce expression of several immediate-early genes, but the molecular mechanisms underlying these responses remain poorly characterized. We studied induction of the proto-oncogene c-fos by PGE2 in mesangial cells as a model of gene regulation by prostanoids. PGE2 induced marked and transient accumulation of c-fos mRNA. Addition of exogenous 8-bromo-cAMP or forskolin failed to induce c-fos mRNA, suggesting that activation of an EP2 receptor linked to adenylate cyclase did not account for induction of c-fos by PGE2. These data contrast with previous experiments in NIH 3T3 cells in which PGE2 induced c-fos by a cAMP-dependent mechanism. Depletion of protein kinase C blocked induction of c-fos mRNA by PGE2, whereas a protein tyrosine kinase inhibitor had no effect. We further showed that PGE2 induces the c-fos gene by increasing the transactivating capacity of the serum-response element. Transient transfections with a CAT fusion gene driven by an AP-1 cis-element demonstrated that although PGE2 markedly induced c-fos, PGE2 did not increase AP-1-driven transcriptional responses. Electrophoretic gel mobility shift assays revealed that PGE2 failed to increase binding of AP-1 complexes to a consensus AP-1 DNA sequence. Taken together, these experiments provide evidence for a cAMP-independent, protein kinase C-dependent pathway linking a PGE2 receptor on the plasma membrane to transcriptional activation in the nucleus. Regulation of gene transcription by PGE2 probably involves c-fos induction without concomitant activation of AP-1.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7525323     DOI: 10.1006/excr.1994.1325

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  7 in total

1.  Effects of different polyunsaturated fatty acids on growth-related early gene expression and cell growth.

Authors:  A Sellmayer; U Danesch; P C Weber
Journal:  Lipids       Date:  1996-03       Impact factor: 1.880

2.  Omega 3 but not omega 6 fatty acids inhibit AP-1 activity and cell transformation in JB6 cells.

Authors:  G Liu; D M Bibus; A M Bode; W Y Ma; R T Holman; Z Dong
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-19       Impact factor: 11.205

3.  Effect of cyclic AMP and prostaglandin E2 on the induction of nitric oxide- and prostanoid-forming pathways in cultured rat mesangial cells.

Authors:  R M Nüsing; T Klein; J Pfeilschifter; V Ullrich
Journal:  Biochem J       Date:  1996-01-15       Impact factor: 3.857

Review 4.  Regulation of interleukin-12 gene expression and its anti-tumor activities by prostaglandin E2 derived from mammary carcinomas.

Authors:  Maki Mitsuhashi; Jianguo Liu; Shanjin Cao; Xiaoyan Shi; Xiaojing Ma
Journal:  J Leukoc Biol       Date:  2004-05-03       Impact factor: 4.962

5.  Prostaglandin E2 regulates its own inactivating enzyme, 15-PGDH, by EP2 receptor-mediated cervical cell-specific mechanisms.

Authors:  A Hari Kishore; David Owens; R Ann Word
Journal:  J Clin Endocrinol Metab       Date:  2014-01-28       Impact factor: 5.958

6.  Cyclooxygenase-1 is up-regulated in cervical carcinomas: autocrine/paracrine regulation of cyclooxygenase-2, prostaglandin e receptors, and angiogenic factors by cyclooxygenase-1.

Authors:  Kurt J Sales; Arieh A Katz; Bruce Howard; Robbert P Soeters; Robert P Millar; Henry N Jabbour; Roggert P Soeters
Journal:  Cancer Res       Date:  2002-01-15       Impact factor: 12.701

Review 7.  Immunosuppressive metabolites in tumoral immune evasion: redundancies, clinical efforts, and pathways forward.

Authors:  Maria Rain Jennings; David Munn; John Blazeck
Journal:  J Immunother Cancer       Date:  2021-10       Impact factor: 13.751

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.